Financial

CONMED CORPORATION (NASDAQ:CNMD) ANALYST RATING UPDATE

Wall Street analysts polled by Zacks Research have given CONMED Corporation (NASDAQ:CNMD) a rating of 2 on a consensus basis. Using a simplified scale where 1 is a Strong Buy and 5 a Strong Sell, this is the average number of the 6 brokerages surveyed. The stock had a rating of 2 when analyst ratings were averaged three months ago.

The covering analysts have a one year price objective of $59 on CONMED Corporation (NASDAQ:CNMD). The most bullish brokerage firm sees the stock heading to $65 , while the most conservative estimate has an objective of $51.

Earnings Look

Wall Street will be paying close attention when CONMED Corporation reports their next quarterly earnings report on 2015-07-21. Analysts polled by Zacks are expecting earnings per share of $0.43 for the period ending 2015-06-30. This is the consensus number based on the 6 broker predictions taken into consideration. On a longer term basis, sell-side analysts who project long term growth are expecting earnings of $15. This is the three to five year estimate for both earnings and sales.

Most recently CONMED Corporation reported actual earnings of $0.42 per share for the quarter ending on 2015-03-31. The actual reported number was $0.01 away from what analysts had expected, yielding a surprise factor of 2.44%.

CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company’s powered instruments product line includes the MPower battery system. The Company’s patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.

Print Friendly, PDF & Email
Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close